{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T07:28:21Z","timestamp":1791185301333,"version":"4.1.0"},"reference-count":24,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2012,10,1]],"date-time":"2012-10-01T00:00:00Z","timestamp":1349049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,10,1]],"date-time":"2012-10-01T00:00:00Z","timestamp":1349049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2012,10,1]],"date-time":"2012-10-01T00:00:00Z","timestamp":1349049600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["international-journal-of-gynecological-cancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Gynecological Cancer"],"published-print":{"date-parts":[[2012,10]]},"DOI":"10.1097\/igc.0b013e31826a3559","type":"journal-article","created":{"date-parts":[[2012,9,8]],"date-time":"2012-09-08T04:26:56Z","timestamp":1347078416000},"page":"1337-1343","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":86,"title":["Maximal Cytoreduction in Patients With FIGO Stage IIIC to Stage IV Ovarian, Fallopian, and Peritoneal Cancer in Day-to-Day Practice"],"prefix":"10.1016","volume":"22","author":[{"given":"Mathieu","family":"Luyckx","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Leblanc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Filleron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Morice","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emile","family":"Darai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Marc","family":"Classe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gwena\u00ebl","family":"Ferron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eberhard","family":"Stoeckle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Pomel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00e9n\u00e9dicte","family":"Vinet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth","family":"Chereau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9cile","family":"Bergzoll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denis","family":"Querleu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1097\/IGC.0b013e31826a3559_bb0005","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1002\/ijc.20649","article-title":"Ovarian cancer in Europe: cross-sectional trends in incidence and mortality in 28 countries, 1953\u20132000","volume":"113","author":"Bray","year":"2005","journal-title":"IntJ Cancer."},{"key":"10.1097\/IGC.0b013e31826a3559_bb0010","first-page":"101","article-title":"Surgical resection of tumor bulk in the primary treatment of ovarian carcinoma","volume":"42","author":"Griffiths","year":"1975","journal-title":"Natl Cancer Inst Monogr."},{"key":"10.1097\/IGC.0b013e31826a3559_bb0015","first-page":"413","article-title":"Primary cytoreductive surgery for epithelial ovarian cancer","volume":"61","author":"Hacker","year":"1983","journal-title":"Obstet Gynecol."},{"key":"10.1097\/IGC.0b013e31826a3559_bb0020","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/0090-8258(84)90040-4","article-title":"Stage III epithelial ovarian cancer: the role of maximal surgical reduction","volume":"18","author":"Delgado","year":"1984","journal-title":"Gynecol Oncol."},{"key":"10.1097\/IGC.0b013e31826a3559_bb0025","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1200\/JCO.1988.6.6.983","article-title":"The impact of aggressive debulking surgery and cisplatin-based chemotherapy on progression-free survival in stage III and IV ovarian carcinoma","volume":"6","author":"Piver","year":"1988","journal-title":"J Clin Oncol."},{"key":"10.1097\/IGC.0b013e31826a3559_bb0030","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1006\/gyno.1998.4955","article-title":"Complete cytoreductive surgery is feasible and maximizes survival in patients with advanced epithelial ovarian cancer: a prospective study","volume":"69","author":"Eisenkop","year":"1998","journal-title":"Gynecol Oncol."},{"key":"10.1097\/IGC.0b013e31826a3559_bb0035","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.ygyno.2006.03.051","article-title":"What is the optimal goal of primary cytoreductive surgery for bulky stage IIIC epithelial ovarian carcinoma (EOC)?","volume":"103","author":"Chi","year":"2006","journal-title":"Gynecol Oncol."},{"key":"10.1097\/IGC.0b013e31826a3559_bb0040","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/j.ygyno.2006.06.028","article-title":"The addition of extensive upper abdominal surgery to achieve optimal cytoreduction improves survival in patients with stages IIIC\u2013IV epithelial ovarian cancer","volume":"103","author":"Eisenhauer","year":"2006","journal-title":"Gynecol Oncol."},{"key":"10.1097\/IGC.0b013e31826a3559_bb0045","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.ygyno.2009.03.018","article-title":"Improved progression-free and overall survival in advanced ovarian cancer as a result of a change in surgical paradigm","volume":"114","author":"Chi","year":"2009","journal-title":"Gynecol Oncol."},{"key":"10.1097\/IGC.0b013e31826a3559_bb0050","doi-asserted-by":"crossref","first-page":"676.e1","DOI":"10.1016\/j.ajog.2007.10.495","article-title":"Relationship among surgical complexity, short term morbidity, and overall survival in primary surgery for advanced ovarian cancer","volume":"197","author":"Aletti","year":"2007","journal-title":"Am J Obstet Gynecol."},{"key":"10.1097\/IGC.0b013e31826a3559_bb0055","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.ygyno.2008.10.011","article-title":"Incidence and management of pancreatic leaks after splenectomy with distal pancreatectomy performed during primary cytoreductive surgery for advanced ovarian, peritoneal and fallopian tube cancer","volume":"112","author":"Kehoe","year":"2009","journal-title":"Gynecol Oncol."},{"key":"10.1097\/IGC.0b013e31826a3559_bb0060","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1111\/j.1471-0528.2009.02214.x","article-title":"Pulmonary morbidity of diaphragmatic surgery for stage III\/IV ovarian cancer","volume":"116","author":"Ch\u00e9reau","year":"2009","journal-title":"BJOG."},{"key":"10.1097\/IGC.0b013e31826a3559_bb0065","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/0090-8258(92)90100-W","article-title":"The influence of cytoreductive surgery on recurrence free interval and survival in small-volume stage III epithelial ovarian cancer: a Gynecologic Oncology Group study","volume":"47","author":"Hoskins","year":"1992","journal-title":"Gynecol Oncol."},{"key":"10.1097\/IGC.0b013e31826a3559_bb0070","first-page":"81","article-title":"Elective surgery in recurrent colon cancer with peritoneal seeding: when not to proceed","volume":"20","author":"Esquivel","year":"1999","journal-title":"Geka Chiryo."},{"key":"10.1097\/IGC.0b013e31826a3559_bb0075","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1002\/jso.21068","article-title":"The intraoperative staging systems in the management of peritoneal surface malignancy","volume":"98","author":"Gomez Portilla","year":"2008","journal-title":"J Surg Oncol."},{"key":"10.1097\/IGC.0b013e31826a3559_bb0080","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.ygyno.2007.10.001","article-title":"The impact of bulky upper abdominal disease cephalad to the greater omentum on surgical outcome for stage IIIC epithelial ovarian, fallopian tube, and primary peritoneal cancer","volume":"108","author":"Zivanovic","year":"2008","journal-title":"Gynecol Oncol."},{"key":"10.1097\/IGC.0b013e31826a3559_bb0085","series-title":"Peritoneal Carcinomatosis: Principles of Management","first-page":"368","article-title":"Clinical research methodologies in the diagnosis and staging of patients with peritoneal carcinomatosis","author":"Jacquet","year":"1996"},{"key":"10.1097\/IGC.0b013e31826a3559_bb0090","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S0021-7697(04)95334-3","article-title":"Management of malignant epithelial tumor of the ovary","volume":"141","author":"Pomel","year":"2004","journal-title":"J Chir (Paris)."},{"key":"10.1097\/IGC.0b013e31826a3559_bb0095","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1097\/IGC.0b013e31821b2568","article-title":"et al; on behalf of the participants of the 4th Ovarian Cancer Consensus Conference (OCCC) 2010. Gynecologic Cancer InterGroup (GCIG) consensus statement on clinical trials in ovarian cancer: report from the Fourth Ovarian Cancer Consensus Conference","volume":"21","author":"Gavin","year":"2011","journal-title":"Int J Gynecol Cancer."},{"key":"10.1097\/IGC.0b013e31826a3559_bb0100","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.ygyno.2011.02.035","article-title":"Intraoperative fluorescence imaging of peritoneal dissemination of ovarian carcinomas","volume":"122","author":"Mery","year":"2011","journal-title":"A preclinical study. Gynecol Oncol."},{"key":"10.1097\/IGC.0b013e31826a3559_bb0105","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.ygyno.2010.12.328","article-title":"Celiac lymph node resection and porta hepatis disease resection in advanced or recurrent epithelial ovarian, fallopian tube, and primary peritoneal cancer","volume":"121","author":"Martinez","year":"2011","journal-title":"Gynecol Oncol."},{"key":"10.1097\/IGC.0b013e31826a3559_bb0110","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1002\/cncr.24149","article-title":"Role of surgical outcome as prognostic factor in advanced epithelial ovarian cancer: a combined exploratory analysis of 3 prospectively randomized phase 3 multicenter trials","volume":"115","author":"du Bois","year":"2009","journal-title":"Cancer."},{"key":"10.1097\/IGC.0b013e31826a3559_bb0115","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1200\/JCO.2002.20.5.1248","article-title":"Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis","volume":"20","author":"Bristow","year":"2002","journal-title":"J Clin Oncol."},{"key":"10.1097\/IGC.0b013e31826a3559_bb0120","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1056\/NEJMoa0908806","article-title":"Neoadjuvant chemotherapy or primary surgery in stage IIIC or IV ovarian cancer. European Organization for Research and Treatment of Cancer-Gynaecological Cancer Group; NCIC Clinical Trials Group","volume":"363","author":"Vergote","year":"2010","journal-title":"N Engl J Med."}],"container-title":["International Journal of Gynecological Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X24025477?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X24025477?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1097\/IGC.0b013e31826a3559","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T01:08:56Z","timestamp":1753232936000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1048891X24025477"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10]]},"references-count":24,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2012,10]]}},"alternative-id":["S1048891X24025477"],"URL":"https:\/\/doi.org\/10.1097\/igc.0b013e31826a3559","relation":{},"ISSN":["1048-891X"],"issn-type":[{"value":"1048-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2012,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Maximal Cytoreduction in Patients With FIGO Stage IIIC to Stage IV Ovarian, Fallopian, and Peritoneal Cancer in Day-to-Day Practice","name":"articletitle","label":"Article Title"},{"value":"International Journal of Gynecological Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1097\/IGC.0b013e31826a3559","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright Copyright \u00a9 2012 by IGCS and ESGO","name":"copyright","label":"Copyright"}]}}